THE BLUEPRINT FOR A HEPATITIS- FREE FUTURE: INNOVATION IN ACTION

Abstract

Hepatitis is a leading cause of morbidity and mortality. It is a significant global public health challenge, affecting more than 300 million people worldwide. Achieving a hepatitis free future requires an integrated approach that combines medical innovation, public health initiatives, and equitable healthcare delivery. Although there are many vaccines and antiviral hepatitis therapies that have gradually improved disease prevention and management, millions of individuals remain undiagnosed or lack access to timely treatment. This paper explores the latest advancements driving the fight against viral hepatitis, including rapid point-of- care diagnostics, artificial intelligence-assisted disease surveillance, direct-acting antiviral therapies for Hepatitis C, emerging therapeutic strategies for hepatitis B, and gene-editing technologies and digital health platforms for patient monitoring and treatment adherence. It also highlights the importance of universal vaccination, early screening, public awareness, and strengthened healthcare policies in reducing the global burden of hepatitis. By examining current challenges and innovative solutions, this review emphasizes the need for collaborative efforts among researchers and health care professionals, policymakers, and international organisations to achieve the World Health Organisation's goal of eliminating the viral hepatitis threat by 2030. The integration of cutting- edge technologies with effective